144 related articles for article (PubMed ID: 7512547)
1. Susceptibility of Pseudomonas pseudomallei to some newer beta-lactam antibiotics and antibiotic combinations using time-kill studies.
Smith MD; Wuthiekanun V; Walsh AL; White NJ
J Antimicrob Chemother; 1994 Jan; 33(1):145-9. PubMed ID: 7512547
[No Abstract] [Full Text] [Related]
2. Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia.
Crowe A; McMahon N; Currie BJ; Baird RW
Int J Antimicrob Agents; 2014 Aug; 44(2):160-2. PubMed ID: 24924662
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of bla(PenA) and bla(OXA) in Burkholderia pseudomallei Isolated from Patients at Sappasitthiprasong Hospital and Their Susceptibility to Ceftazidime and Carbapenems.
Panya M; Thirat S; Wanram S; Panomket P; Nilsakul J
J Med Assoc Thai; 2016 Jan; 99 Suppl 1():S12-6. PubMed ID: 26817233
[TBL] [Abstract][Full Text] [Related]
4. Burkholderia pseudomallei class a beta-lactamase mutations that confer selective resistance against ceftazidime or clavulanic acid inhibition.
Tribuddharat C; Moore RA; Baker P; Woods DE
Antimicrob Agents Chemother; 2003 Jul; 47(7):2082-7. PubMed ID: 12821450
[TBL] [Abstract][Full Text] [Related]
5. Activity of tigecycline in the treatment of acute Burkholderia pseudomallei infection in a murine model.
Feterl M; Govan B; Engler C; Norton R; Ketheesan N
Int J Antimicrob Agents; 2006 Nov; 28(5):460-4. PubMed ID: 17046208
[TBL] [Abstract][Full Text] [Related]
6. Five-year surveillance for Burkholderia pseudomallei in Thailand from 2000 to 2004: prevalence and antimicrobial susceptibility.
Paveenkittiporn W; Apisarnthanarak A; Dejsirilert S; Trakulsomboon S; Thongmali O; Sawanpanyalert P; Aswapokee N
J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S46-52. PubMed ID: 21298845
[TBL] [Abstract][Full Text] [Related]
7. Burkholderia pseudomallei acquired ceftazidime resistance due to gene duplication and amplification.
Chirakul S; Somprasong N; Norris MH; Wuthiekanun V; Chantratita N; Tuanyok A; Schweizer HP
Int J Antimicrob Agents; 2019 May; 53(5):582-588. PubMed ID: 30639528
[TBL] [Abstract][Full Text] [Related]
8. Variations in ceftazidime and amoxicillin-clavulanate susceptibilities within a clonal infection of Burkholderia pseudomallei.
Sam IC; See KH; Puthucheary SD
J Clin Microbiol; 2009 May; 47(5):1556-8. PubMed ID: 19297597
[TBL] [Abstract][Full Text] [Related]
9. Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei from Thailand.
Saiprom N; Amornchai P; Wuthiekanun V; Day NP; Limmathurotsakul D; Peacock SJ; Chantratita N
Int J Antimicrob Agents; 2015 May; 45(5):557-9. PubMed ID: 25758020
[No Abstract] [Full Text] [Related]
10. Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis.
Jenney AW; Lum G; Fisher DA; Currie BJ
Int J Antimicrob Agents; 2001 Feb; 17(2):109-13. PubMed ID: 11165114
[TBL] [Abstract][Full Text] [Related]
11. Development of resistance to ceftazidime and co-amoxiclav in Pseudomonas pseudomallei.
Dance DA; Wuthiekanun V; Chaowagul W; Suputtamongkol Y; White NJ
J Antimicrob Chemother; 1991 Aug; 28(2):321-4. PubMed ID: 1723404
[No Abstract] [Full Text] [Related]
12. Farnesol increases the susceptibility of Burkholderia pseudomallei biofilm to antimicrobials used to treat melioidosis.
Castelo-Branco DS; Riello GB; Vasconcelos DC; Guedes GM; Serpa R; Bandeira TJ; Monteiro AJ; Cordeiro RA; Rocha MF; Sidrim JJ; Brilhante RS
J Appl Microbiol; 2016 Mar; 120(3):600-6. PubMed ID: 26669506
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility patterns of Burkholderia pseudomallei among melioidosis cases in Kedah, Malaysia.
Hassan MR; Vijayalakshmi N; Pani SP; Peng NP; Mehenderkar R; Voralu K; Michael E
Southeast Asian J Trop Med Public Health; 2014 May; 45(3):680-8. PubMed ID: 24974653
[TBL] [Abstract][Full Text] [Related]
14. Postantibiotic effects and Burkholderia (Pseudomonas) pseudomallei: evaluation of current treatment.
Walsh AL; Smith MD; Wuthiekanun V; White NJ
Antimicrob Agents Chemother; 1995 Oct; 39(10):2356-8. PubMed ID: 8619598
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic susceptibility of 50 clinical isolates of Burkholderia pseudomallei from Singapore.
Sivalingam SP; Sim SH; Aw LT; Ooi EE
J Antimicrob Chemother; 2006 Nov; 58(5):1102-3. PubMed ID: 16951412
[No Abstract] [Full Text] [Related]
16. In-vitro activity of carbapenem antibiotics against beta-lactam susceptible and resistant strains of Burkholderia pseudomallei.
Smith MD; Wuthiekanun V; Walsh AL; White NJ
J Antimicrob Chemother; 1996 Mar; 37(3):611-5. PubMed ID: 9182118
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic Resistance Markers in Burkholderia pseudomallei Strain Bp1651 Identified by Genome Sequence Analysis.
Bugrysheva JV; Sue D; Gee JE; Elrod MG; Hoffmaster AR; Randall LB; Chirakul S; Tuanyok A; Schweizer HP; Weigel LM
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28396541
[No Abstract] [Full Text] [Related]
18. Optical microscopy reveals the dynamic nature of B. pseudomallei morphology during β-lactam antimicrobial susceptibility testing.
McLaughlin HP; Bugrysheva J; Sue D
BMC Microbiol; 2020 Jul; 20(1):209. PubMed ID: 32677888
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents.
Thibault FM; Hernandez E; Vidal DR; Girardet M; Cavallo JD
J Antimicrob Chemother; 2004 Dec; 54(6):1134-8. PubMed ID: 15509614
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional and post-transcriptional regulation of PenA β-lactamase in acquired Burkholderia pseudomallei β-lactam resistance.
Chirakul S; Norris MH; Pagdepanichkit S; Somprasong N; Randall LB; Shirley JF; Borlee BR; Lomovskaya O; Tuanyok A; Schweizer HP
Sci Rep; 2018 Jul; 8(1):10652. PubMed ID: 30006637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
